Victory Capital Management Inc Arcturus Therapeutics Holdings Inc. Transaction History

Victory Capital Management Inc

  • $99 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 06, 2023
SELL
$25.44 - $37.35 $18,062 - $26,518
-710 Reduced 2.88%
23,970 $612,000
Q2 2023

Jul 27, 2023
BUY
$23.94 - $32.36 $590,839 - $798,644
24,680 New
24,680 $707,000
Q2 2021

Aug 03, 2021
SELL
$25.79 - $42.11 $127,454 - $208,107
-4,942 Closed
0 $0
Q1 2021

May 04, 2021
BUY
$38.75 - $86.92 $191,502 - $429,558
4,942 New
4,942 $204,000

Others Institutions Holding ARCT

# of Institutions
179
Shares Held
25.6M
Call Options Held
195K
Put Options Held
133K
View Full List

About Arcturus Therapeutics Holdings Inc.

ARCT Quotes by TradingView
  • Ticker ARCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,576,400
  • Market Cap $439M
  • Description
  • Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...
More about ARCT
Track This Portfolio

Track Victory Capital Management Inc Portfolio

Follow Victory Capital Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email